Certified by Founder Lodge
T. Rowe Price
United States - Baltimore, Maryland
INVESTOR
1 Disclosed Funding Rounds $223,000,000
18 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
T. Rowe Price is an asset management firm focused on delivering global investment management excellence and retirement services that investors can rely on—now, and over the long term.
Head
| Company | Date | Round | Raised |
|---|---|---|---|
 Cleerly |
July, 25 ,2022 | Series C | $223,000,000 |
 Flexe |
July, 07 ,2022 | Series D | $119,000,000 |
 CARGO Therapeutics |
March, 06 ,2023 | Series A | $200,000,000 |
 Tessera Therapeutics |
April, 19 ,2022 | Series C | $300,000,000 |
 Saluda Medical |
April, 17 ,2023 | Unknown | $150,000,000 |
 KoBold Metals |
June, 21 ,2023 | Unknown | $195,000,000 |
 ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
 Genesis Therapeutics |
August, 22 ,2023 | Series B | $200,000,000 |
 Sortera Technologies, Inc. |
August, 31 ,2023 | Series C | $30,500,000 |
 Generate:Biomedicines |
September, 18 ,2023 | Series C | $273,000,000 |
 Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
 Stash |
October, 16 ,2023 | Unknown | $40,000,000 |
 Apiture |
November, 15 ,2023 | Unknown | $10,000,000 |
 RefleXion Medical |
November, 17 ,2023 | Unknown | $105,000,000 |
 Odyssey Therapeutics |
December, 06 ,2023 | Series C | $101,000,000 |
 Lambda |
February, 16 ,2024 | Series C | $320,000,000 |
 Sionna Therapeutics |
March, 07 ,2024 | Series C | $182,000,000 |
 Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
Founderpath
Truework
Finix
Farther
TeamApt Inc.
OTPLESS | $3,500,000 | (May 17, 2024)
Watershed Health | $13,600,000 | (May 17, 2024)
Aeropay | $20,000,000 | (May 17, 2024)
c/side | $1,700,000 | (May 17, 2024)
SINE Digital | $2,500,000 | (May 17, 2024)
